CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 276 enrolled
Drug / intervention
Calcichew D3 +2 moredrug
Likely dose
Calcichew D3 500 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02457247
NCT02457247Phase 4Completed
CompareCT.gov

A Randomized, Open-Label, 2-Way Cross-Over, Phase 4 Study to Evaluate Subject Preference and Acceptability of a New Formulation of Calcichew D3 in Adult Patients Eligible for Calcium and Vitamin D Supplementation

Takeda·interventional·Posted May 29, 2015·Updated Oct 25, 2016

In Brief

A Phase 4 clinical trial evaluating Calcichew D3, Adcal-D3, and 1 other intervention for Calcium and Vitamin D Deficiencies. Completed, enrolled 276 participants across 9 sites in 2 countries.

Detailed Summary

The purpose of this study is to compare the preference of Calcichew D3 500/400 (containing 500 mg calcium and 400 IU of vitamin D) with Adcal-D3 600/400 (containing 600 mg of calcium and 400 IU of vitamin D) in Test Group 1, and to compare Calcichew D3 500/800 (containing 500 mg calcium and 800 IU vitamin D) with Kalcipos-D 500/800 (containing 500 mg of calcium and 800 IU of vitamin D) in Test Group 2.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCalcium and Vitamin D Deficiencies
CountriesGermany, United Kingdom
Collaborators--

Timeline

Phase 4CompletedFinished
20162017201820192020202120222023202420252026
First PostedMay 29, 2015
Enrollment StartJun 1, 2015
Primary CompletionAug 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 11.1 years ago

Interventions

Calcichew D3drug

Calcichew D3 500/400 (Calcium 500 mg/400 IU Vitamin D3) Calcichew D3 500/800 (Calcium 500 mg/800 IU Vitamin D3)

Adcal-D3drug

Adcal-D3 (Calcium 600mg/400 IU Vitamin D3)

Kalcipos-Ddrug

Kalcipos-D (Calcium 500mg/800 IU Vitamin D3)